U.S. Insurance Stock News

NasdaqGS:APA
NasdaqGS:APAOil and Gas

Assessing APA (APA) Valuation After Nasdaq Texas Dual Listing And Recent Share Price Momentum

APA (APA) is back in focus after confirming a dual listing on the newly launched Nasdaq Texas exchange, while keeping its primary Nasdaq listing. The move is tied closely to its Houston based energy footprint. See our latest analysis for APA. Beyond the dual listing, APA has been in the spotlight after releasing its 2025 results and issuing production guidance for 2026, with investors reacting through a 30 day share price return of 18.68% and a 1 year total shareholder return of 80.20%,...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

Assessing GeneDx Holdings’s Valuation As New ACMG Genomics And AI Data Spotlight Its Rare Disease Focus

GeneDx Holdings (WGS) is back in focus after announcing 18 accepted abstracts for the 2026 ACMG Annual Meeting, highlighting its work in sequencing, AI supported genomic interpretation, and rare disease data. See our latest analysis for GeneDx Holdings. The ACMG abstracts and February loan agreement with Blackstone come after a sharp share price pullback, with a 90 day share price return of a 41.23% decline and a year to date share price return of a 28.56% decline, even as the 3 year total...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Does Ziff Davis (ZD) Face a Turning Point in Management Credibility Amid Activist Scrutiny?

Ziff Davis recently reported Q4 2025 results showing about a 1.5% revenue decline after earlier guidance for accelerating growth, prompting an investor investigation into whether management’s prior statements were misleading. Soon after, Czech investment group Pale Fire Capital disclosed a 6.9% stake and signaled it may push for changes to Ziff Davis’s capitalization, board composition, and operations, adding an activist dimension to the company’s situation. Against this backdrop of an...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

A Look At Lantheus Holdings (LNTH) Valuation After FDA Approval Of PYLARIFY TruVu

Lantheus Holdings (LNTH) is back in focus after U.S. regulators cleared PYLARIFY TruVu, a new formulation of its PSMA PET imaging agent for prostate cancer that is designed to support larger batch sizes and wider patient access. See our latest analysis for Lantheus Holdings. The PYLARIFY TruVu approval lands after a sharp 1 day share price return of 10.27% and a 30 day share price return of 23.30%. However, the 1 year total shareholder return is a 27.27% decline, indicating short term...
NYSE:YALA
NYSE:YALAInteractive Media and Services

Assessing Yalla Group (YALA) Valuation After New US$150 Million Buyback And Q1 2026 Revenue Guidance

Why Yalla Group (YALA) is back on investors’ radar Yalla Group (YALA) has drawn fresh attention after its board approved a new share repurchase program of up to US$150 million, alongside first quarter 2026 revenue guidance that factors in the timing of Ramadan. See our latest analysis for Yalla Group. Those moves come after a period where the 1 year total shareholder return of 76.9% contrasts with a more muted 0.7% year to date share price return at US$7.11, suggesting recent momentum has...
NYSE:MTD
NYSE:MTDLife Sciences

Why Mettler-Toledo (MTD) Is Down 5.8% After Tariff-Driven Margin Squeeze And Cautious 2025 Outlook

In Q2 2025, Mettler-Toledo International reported marginal revenue growth but weaker gross and operating margins as higher tariffs and macroeconomic pressures weighed on profitability, and management issued cautious full-year 2025 guidance. Even as near-term earnings face pressure, the company is emphasizing bioprocessing and manufacturing onshoring as areas it believes could reshape its longer-term business mix. We’ll now examine how the tariff-driven margin squeeze highlighted in the...
NYSE:RNG
NYSE:RNGSoftware

Is RingCentral’s (RNG) Expanded ESOP a Sign of Strategic Confidence or Ownership Dilution?

RingCentral recently filed a US$176.26 million shelf registration for 5,111,905 Class A shares tied to its employee stock ownership plan and, shortly after, President and COO Kira Makagon sold 22,196 shares under a pre-arranged Rule 10b5-1 plan while retaining 339,545 shares. Together, the ESOP-related shelf and Makagon’s planned share sale highlight how RingCentral is balancing employee equity incentives with leadership’s continuing financial stake in the business. We’ll now assess how the...
NYSE:RCL
NYSE:RCLHospitality

A Look At Royal Caribbean Cruises (RCL) Valuation As Middle East Tensions Lift Oil Prices

Royal Caribbean Cruises (RCL) is back in focus as rising tensions in the Middle East lift oil prices, raising questions about fuel costs, itinerary risks, and how much its hedging policy can soften the blow. See our latest analysis for Royal Caribbean Cruises. At a share price of US$290.55, Royal Caribbean’s 1 day share price return of 4.5% comes after a 30 day share price return decline of 16.5%. Its 1 year total shareholder return of 42.3% and 3 year total shareholder return of over 3.6x...
NYSE:BAH
NYSE:BAHProfessional Services

How Booz Allen Hamilton's Expanded US$1.50 Billion Credit Facility At BAH Has Changed Its Investment Story

On February 27, 2026, Booz Allen Hamilton Holding Corporation amended its long-standing credit agreement, lifting its revolving credit facility from US$1.0 billion to US$1.50 billion, extending maturities to 2031, and refinancing part of its term loans. The amendment also broadens the company’s capacity to take on new debt and return cash via dividends and share repurchases, potentially reshaping its financial flexibility and capital allocation options. Next, we will examine how this...
NYSE:CWEN.A
NYSE:CWEN.ARenewable Energy

Clearway Energy (CWEN.A) Valuation Check As Share Class Conversion Proposal Shifts Voting Power And Liquidity

Clearway Energy (CWEN.A) has proposed amending its certificate of incorporation to automatically convert each Class A common share into a Class C share. This represents a structural shift that could matter for voting power and stock liquidity. See our latest analysis for Clearway Energy. The proposed share class conversion comes after a period where the share price return has been mixed in the short term but stronger over longer horizons, with a 90 day share price return of 15.23% and a 1...
NYSE:DOV
NYSE:DOVMachinery

Assessing Dover (DOV) Valuation After Hillphoenix’s Next Generation CO2 System Launch

Hillphoenix product launch puts Dover’s refrigeration focus in the spotlight Dover (DOV) is back on investors’ radar after its Hillphoenix unit introduced the Next Generation Flex Mini CO2 refrigeration system, which emphasizes operational uptime, serviceability, energy use, and total cost of ownership for food retail and industrial users. See our latest analysis for Dover. At a share price of $211.0, Dover has seen a 7.79% year to date share price return and a 20.00% total shareholder return...
NYSE:TFC
NYSE:TFCBanks

A Look At Truist Financial (TFC) Valuation As It Expands Client Access To Spot Bitcoin ETFs

Truist Financial (TFC) has moved further into digital assets, with Truist Wealth allowing clients to access SEC registered spot bitcoin ETFs from Fidelity and BlackRock, potentially reshaping how some investors view the bank’s broader offering. See our latest analysis for Truist Financial. The recent rollout of spot bitcoin ETF access sits alongside Truist Financial’s leadership changes, including the appointment of a new head of M&A, at a time when the latest share price of US$46.75 comes...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Exact Sciences EHR Outreach Lifts CRC Screening And Fuels Investor Interest

Exact Sciences, Amalgam Rx and Privia Health report materially higher colorectal cancer screening rates using EHR-enabled outreach and at home noninvasive tests. The coordinated program is described as scalable and has surpassed national screening benchmarks during Colorectal Cancer Awareness Month. The initiative focuses on closing screening gaps by embedding screening prompts and workflows directly into clinical systems and patient communications. For investors watching NasdaqCM:EXAS,...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel’s Valuation After New AI And 6G Partnerships With Ericsson Viettel And Infosys

Why Intel’s latest AI and 6G partnerships matter for the stock Intel (INTC) has just lined up a series of AI focused partnerships with Ericsson, Viettel High Tech and Infosys, tying its chips and software more tightly into 6G networks and large scale enterprise AI deployments. See our latest analysis for Intel. Intel’s recent AI and 6G announcements come after a strong 12 months for investors, with a very large 1 year total shareholder return of 128.70%. However, the 30 day share price return...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

A Look At Nurix Therapeutics (NRIX) Valuation After Expanded Equity Distribution Agreement

Why Nurix Therapeutics (NRIX) moved after its latest capital move Nurix Therapeutics (NRIX) recently expanded its equity distribution agreement, giving it room to sell up to $413.65 million of common stock through Piper Sandler. This step directly affects its capital-raising flexibility and potential dilution. See our latest analysis for Nurix Therapeutics. The capital plan arrives after a tougher few months for the share price, with a 30 day share price return showing an 8% decline and a 90...
NYSE:HMN
NYSE:HMNInsurance

A Look At Horace Mann Educators (HMN) Valuation After Recent Mixed Share Performance

Setting the scene for Horace Mann Educators Horace Mann Educators (HMN) has been on investors’ radar after a recent stretch of mixed share performance, including a 3% decline over the past week and a modest gain over the past year. See our latest analysis for Horace Mann Educators. Recent trading has been softer, with a 7-day share price return of -5.18% and a year to date share price return of -6.77%. However, the 1-year total shareholder return of 6.69% and 3-year total shareholder return...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

GigaCloud Technology (GCT) Valuation Check After Earnings Beat Guidance And Share Buyback

GigaCloud Technology (GCT) is back on investor radars after reporting fourth quarter and full year 2025 earnings, issuing first quarter 2026 revenue guidance, and completing a share buyback that reduced its share count. See our latest analysis for GigaCloud Technology. At a share price of US$44.09, GigaCloud Technology has recently delivered a 9.5% 30 day share price return and a three year total shareholder return of about 7x, suggesting momentum is building around the recent earnings beat,...
NYSE:PINS
NYSE:PINSInteractive Media and Services

Pinterest (PINS) Is Up 12.4% After Elliott’s Convertible Deal And New $3.5B Buyback Plan

In early March 2026, Pinterest, Inc. announced a new US$3.50 billion share repurchase plan and completed a US$1.00 billion private placement of 1.75% Convertible Senior Notes to Elliott Associates, L.P., following the expiry of its prior buyback program. This combination of aggressive capital returns and a sizeable convertible investment from activist manager Elliott Investment Management highlights a meaningful shift in Pinterest’s balance sheet structure and capital allocation...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Jazz’s 2025 Net Loss and 2026 Outlook Might Change The Case For Investing In JAZZ

In February 2026, Jazz Pharmaceuticals reported fourth-quarter 2025 results showing revenue rising to US$1.20 billion and net income of US$203.45 million, while full-year revenue increased to US$4.27 billion but swung to a net loss of US$356.15 million. The company also issued 2026 revenue guidance of US$4.25 billion to US$4.50 billion, offering investors a tighter view of expected top-line performance despite the prior-year loss. We’ll now examine how the full-year net loss alongside the...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

A Look At UniQure (QURE) Valuation After Full Year Earnings Spark Sharp Share Price Move

Why uniQure’s Latest Earnings Matter for Investors uniQure (NasdaqGS:QURE) recently released full year 2025 results, reporting revenue of US$16.1 million compared with US$27.12 million a year earlier, and a net loss of US$198.97 million versus US$239.56 million previously. The company also reported a basic loss per share from continuing operations of US$3.46, compared with US$4.92 a year ago, a change that many investors will weigh against the smaller revenue base. See our latest analysis for...
NYSE:SBR
NYSE:SBROil and Gas

How Sabine Royalty Trust’s Higher March Cash Distribution Will Impact Sabine Royalty Trust (SBR) Investors

In early March 2026, Argent Trust Company, as Trustee of Sabine Royalty Trust, declared a cash distribution of US$0.286230 per unit, payable on March 30, 2026, to unitholders of record on March 16, 2026, reflecting primarily December 2025 oil and November 2025 gas production. The higher distribution, supported by increased oil output and improved natural gas pricing despite mixed production volumes, coincided with full-year 2025 results showing modestly lower revenue and net income versus...
NYSE:SDRL
NYSE:SDRLEnergy Services

How Investors May Respond To Seadrill (SDRL) Returning To Losses While Issuing 2026 Revenue Guidance

In late February 2026, Seadrill Limited reported fourth-quarter 2025 results showing year-on-year revenue growth to US$362 million but a shift from net income to a US$10 million net loss, alongside a US$22 million impairment on long-lived assets and full-year 2025 net loss of US$77 million. The company also issued 2026 operating revenue guidance of US$1.40 billion to US$1.45 billion (excluding US$50 million of reimbursables), giving investors fresh insight into expected activity levels and...
NYSE:STZ
NYSE:STZBeverage

Did Constellation Brands' (STZ) CEO Shift Just Redefine Its Leadership-Driven Investment Narrative?

Constellation Brands has appointed Nicholas Fink as its new chief executive officer, succeeding Bill Newlands, with Fink formally taking the role on April 13 and Newlands remaining as a strategic advisor during the transition. This leadership change arrives as the company faces demand challenges, putting Fink’s five years of board experience at the center of how future priorities are set. Now we’ll explore how Nicholas Fink’s appointment as CEO could influence Constellation Brands’ existing...
NasdaqCM:AXGN
NasdaqCM:AXGNMedical Equipment

Should Axogen’s 2026 Growth Guidance Amid Wider Losses Require Action From Axogen (AXGN) Investors?

In February 2026, Axogen, Inc. reported past full-year 2025 results, with sales rising to US$225.21 million from US$187.34 million, while net loss widened to US$15.70 million and basic loss per share from continuing operations increased to US$0.34 from US$0.23. On the same date, Axogen issued new 2026 guidance calling for at least 18% revenue growth to about US$265.70 million and gross margins between 74% and 76%, highlighting management’s confidence in the underlying demand for its nerve...